RESUMO
Reduced appetite combined with increased metabolic rate and decreased lean body mass is a major consequence of disease and other stressors. Studies in rodent species suggest that an understanding of appetite regulation may provide methodologies for intervention to prevent the deterioration of body mass such as observed with cancer or infectious diseases. For example, melanocortin-4 receptor (MC4-R) antagonists have shown a remarkable ability to reverse or prevent cachexia in rodents with sarcoma or treated with endotoxin. Studies in sheep have indicated that a number of peptide neurotransmitters may have a role in regulating appetite in this species. For example, agouti related protein mRNA and protein levels are dramatically altered with fasting in sheep. Moreover, agouti related protein, neuropeptide Y, melanin concentrating hormone and orexin are potent stimuli to increase feed intake in sheep. Recent studies have indicated that one of these neurotransmitters, NPY, can work in principal to improve appetite in endotoxin-treated sheep. Current studies are examining the role that MC4-R antagonists may have in the prevention or correction of body mass wasting diseases as well as practical applications in animal production.
Assuntos
Modelos Animais de Doenças , Receptor Tipo 4 de Melanocortina/antagonistas & inibidores , Receptor Tipo 4 de Melanocortina/fisiologia , Ovinos , Proteína Relacionada com Agouti , Animais , Regulação do Apetite , Caquexia/tratamento farmacológico , Caquexia/fisiopatologia , Doença , Jejum , Transtornos da Alimentação e da Ingestão de Alimentos/tratamento farmacológico , Alimentos , Peptídeos e Proteínas de Sinalização Intercelular , Neuropeptídeos/fisiologia , Proteínas/fisiologia , Doenças dos Ovinos/fisiopatologiaRESUMO
Melanin-concentrating hormone (MCH) stimulates feeding when injected intracerebroventricularly (ICV) in rats. At present it is not clear whether the function of MCH is similar in ruminants, which are species with a continuous delivery of nutrients. Therefore the current investigation sought to determine the role of MCH in sheep. In the first experiment, six, castrate male sheep were satiated and received one of four treatments [saline, 0.1, or 1.0 nmol/kg MCH, and NPY (0.1 nmol/kg)] injected ICV over 30s, then infused ICV for 6 h ( approximately 500 microl/h). Food intake was measured for 2 h before and at 2, 4, 6, 8, 12 and 24 h. In this experiment, feed intake was increased (PAssuntos
Ingestão de Alimentos/efeitos dos fármacos
, Hormônios Hipotalâmicos/administração & dosagem
, Melaninas/administração & dosagem
, Hormônios Hipofisários/administração & dosagem
, Ovinos/fisiologia
, Animais
, Sequência de Bases
, Ingestão de Alimentos/fisiologia
, Privação de Alimentos/fisiologia
, Hormônios Hipotalâmicos/genética
, Hipotálamo/efeitos dos fármacos
, Hipotálamo/metabolismo
, Imuno-Histoquímica/veterinária
, Injeções Intraventriculares/veterinária
, Masculino
, Melaninas/genética
, Dados de Sequência Molecular
, Neuropeptídeo Y/metabolismo
, Hormônios Hipofisários/genética
, RNA/química
, RNA/genética
, Distribuição Aleatória
, Reação em Cadeia da Polimerase Via Transcriptase Reversa/veterinária
, Alinhamento de Sequência
, Ovinos/metabolismo
RESUMO
Infectious disease processes cause physiological adaptations in animals to reorder nutrient partitioning and other functions to support host survival. Endocrine, immune and nervous systems largely mediate this process. Using endotoxin injection as a model for catabolic disease processes (such as bacterial septicemia), we have focused our attention on regulation of growth hormone (GH) and luteinizing hormone (LH) secretion in sheep. Endotoxin produces an increase in plasma GH and a decrease in plasma LH concentrations. This pattern can be reproduced, in part, by administration of various cytokines. Antagonists to both interleukin-1 (IL-1) and tumor necrosis factor (TNF) given intravenously (IV) prevented the endotoxin-stimulated increase in GH. Since endotoxin will directly stimulate GH and LH release from cultured pituitary cells, the data suggest a pituitary site of action of the endotoxin to regulate GH. Studies with portal vein cannulated sheep indicated that gonadotropin releasing hormone was inhibited by endotoxin, suggesting a central site of action of endotoxin to regulate LH. However, other studies suggest that endotoxin may also regulate LH secretion at the pituitary. Thus, IL-1 and TNF regulate GH release from the pituitary gland while endotoxin induces a central inhibition of LH release.
Assuntos
Endotoxinas/farmacologia , Hormônio do Crescimento/sangue , Hormônio Luteinizante/sangue , Ovinos/sangue , Animais , Endotoxemia , Feminino , Humanos , Hipotálamo/metabolismo , Interleucina-1/farmacologia , Hormônio Luteinizante/metabolismo , Fator de Necrose Tumoral alfa/farmacologiaRESUMO
Administration of endotoxin suppresses circulating concentration of luteinizing hormone (LH) in a number of species, including rats, sheep, cattle, and non-human primates. Specifically, endotoxin administration decreases circulating concentration of LH and LH pulses frequency in castrated male sheep. Endotoxin could alter circulating concentrations of LH via actions at the hypothalamus through altered GnRH production and/or release, or endotoxin could alter circulating concentrations of LH at the level of the pituitary via inhibition of LH production and release or inhibition of LH in response to GnRH. The site of endotoxin suppression of circulating concentrations of LH as well as possible mediators of endotoxin suppression of circulating concentrations of LH, including cortiocotropin-releasing hormone, arginine vasopressin, glucocorticoids, inflammatory cytokines, prostaglandins, and opioids, are discussed.
Assuntos
Endotoxinas/farmacologia , Hormônio Luteinizante/antagonistas & inibidores , Animais , Hormônio Liberador de Gonadotropina/fisiologia , Hipotálamo/efeitos dos fármacos , Hormônio Luteinizante/sangue , Hormônio Luteinizante/metabolismo , Masculino , Orquiectomia , Hipófise/efeitos dos fármacos , OvinosRESUMO
Melanocortin-4 receptors (MC4R) are key factors in the depression of appetite during disease. This study was designed to determine the role of agouti-related protein (AgRP) in the effect of endotoxin (lipopolysaccharide, LPS) on appetite. Sheep received an intracerebroventricular injection of either saline or AgRP (0.5 nmol/kg of BW) 1 h before intravenous injection of either saline or LPS (0.6 microg/kg of BW) at time 0 and again at 4 h. Agouti-related protein prevented the reduction in feed intake due to LPS (P < 0.05). In a second experiment, AgRP gene expression was unaffected at 3 h and increased (P < 0.01) at 6 h after LPS. Immunohistochemical evidence indicated that there was an increase in the percentage of AgRP neurons with c-Fos immunoreactive nuclei 6 h after sheep were injected with LPS (P < 0.04) and a corresponding decrease in a-melanocyte-stimulating hormone neurons coexpressing c-Fos (P < 0.001). In situ hybridization provided evidence for an increase in AgRP gene expression and a decrease in proopiomelanocortin gene expression 6 h after LPS (P < 0.05). In a final experiment, physiological elevation of orexigenic agents by short-term fasting kept feed intake at the same level as controls, in spite of the presence of LPS, similar to the effects of AgRP in Exp. 1. The AgRP inhibition of the MC4R prevents appetite inhibition in response to LPS and well after LPS inhibition of feed intake, both AgRP and a-melanocyte-stimulating hormone may change in a pattern that favors appetite increases. These studies support the notion of the MC4R as a critical component of the mechanism for appetite suppression due to endotoxin.